Matches in Nanopublications for { <http://bio2rdf.org/drugbank:DB05928> ?p ?o ?g. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB05928 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05928 label "CHIR-258 [drugbank:DB05928]" assertion.
- drugbank:DB05928 seeAlso DB05928 assertion.
- drugbank:DB05928 description "CHIR-258 is an orally active small molecule that exhibits potent inhibitory activity against multiple RTKs involved in tumor growth and angiogenesis. Preclinical data show that CHIR-258 works to inhibit multiple kinases associated with different cancers, including acute myeloid leukemia (AML) and multiple myeloma. Chiron currently has three ongoing Phase I clinical trials for CHIR-258." assertion.
- drugbank:DB05928 identifier "drugbank:DB05928" assertion.
- drugbank:DB05928 title "CHIR-258" assertion.
- drugbank:DB05928 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB05928 drugbank_vocabulary:drugbank-id "DB05928" assertion.
- drugbank:DB05928 bio2rdf_vocabulary:x-identifiers.org DB05928 assertion.
- drugbank:DB05928 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05928" assertion.
- drugbank:DB05928 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05928 bio2rdf_vocabulary:identifier "DB05928" assertion.